$106.92
Price
$12.1B
Market Cap
31.4
P/E Ratio
10.3
Forward P/E
$3.41
EPS (TTM)
—
Dividend Yield
$231M
Cash
$2.1B
Total Debt
113M
Shares Out
$61.23
$109.66
52-Week Range
Institutional Ownership of Halozyme Therapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Halozyme Therapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2020-Q1 | |||||
| SELL | EXIT | — | — | $19.43 | |
| 2018-Q4 | |||||
| SELL | -88.2% | 20.0K | $293000 | $15.79 | |
Insider Trading for Halozyme Therapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.